EUVIMEDEUVIMED entdecken
Crossref

Medicamenteuze behandeling van kinderen en jongeren met het syndroom van Gilles de la Tourette, met comorbide ADHD en obsessieve-compulsieve stoornis: casus en systematisch literatuuroverzicht

S. BAYERGI, M. DANCKAERTS

Tijdschrift voor Geneeskunde en Gezondheidszorg · 12.06.2026

DOI: 10.47671/tvg.82.26.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tijdschrift voor Geneeskunde en Gezondheidszorg, online erschienen am 12.06.2026. Verfasst von S. BAYERGI und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacological treatment of children and adolescents with Gilles de la Tourette syndrome and comorbid ADHD and obsessive–compulsive disorder: a case report and systematic literature review Gilles de la Tourette syndrome (GTS) is frequently associated with psychiatric comorbidity, most notably attention-deficit/hyperactivity disorder (ADHD) and obsessive–compulsive disorder (OCD). While clinical guidelines and research data are available for the pharmacological treatment of combinations of 2 of these conditions, literature specifically addressing pharmacological treatment when GTS, ADHD, and OCD co-occur remains scarce. This article presents a case description of a 7-year-old girl with GTS, ADHD, and OCD, combined with a systematic literature review of pharmacological treatment strategies for GTS with comorbid ADHD and/or OCD. The literature search was conducted in PubMed and Embase and focused on studies involving children and adolescents. No studies were identified that primarily investigated pharmacological treatment of the full triad of GTS, ADHD, and OCD. The included studies addressed treatment of GTS with comorbid ADHD or GTS with comorbid OCD, with the presence of a third comorbid condition generally reported only descriptively. These studies suggest that stimulant and non-stimulant medications may be effective for ADHD without consistent worsening of tics, that selective serotonin reuptake inhibitors (SSRIs) remain the first-line treatment for OCD, and that augmentation with antipsychotics such as aripiprazole or risperidone may contribute to the reduction of both tic and obsessive–compulsive symptoms. Aripiprazole was associated with improvements across multiple symptom domains in several studies. The presented case illustrates the clinical complexity of concurrent tic, ADHD, and obsessive–compulsive symptoms and highlights the importance of an individualized, symptom-oriented treatment approach. In the absence of explicit guidelines for the full triad, treatment decisions in clinical practice are necessarily based on extrapolation from studies addressing dyadic comorbidity and on careful monitoring of therapeutic effects and adverse events across multiple symptom domains.

Zitieren

APA

BAYERGI, S., & DANCKAERTS, M. (2026). Medicamenteuze behandeling van kinderen en jongeren met het syndroom van Gilles de la Tourette, met comorbide ADHD en obsessieve-compulsieve stoornis: casus en systematisch literatuuroverzicht. Tijdschrift voor Geneeskunde en Gezondheidszorg. https://doi.org/10.47671/tvg.82.26.018

Vancouver

BAYERGI S, DANCKAERTS M. Medicamenteuze behandeling van kinderen en jongeren met het syndroom van Gilles de la Tourette, met comorbide ADHD en obsessieve-compulsieve stoornis: casus en systematisch literatuuroverzicht. Tijdschrift voor Geneeskunde en Gezondheidszorg. 2026. doi:10.47671/tvg.82.26.018

BibTeX
@article{BAYERGI2026,
  author = {BAYERGI, S. and DANCKAERTS, M.},
  title = {Medicamenteuze behandeling van kinderen en jongeren met het syndroom van Gilles de la Tourette, met comorbide ADHD en obsessieve-compulsieve stoornis: casus en systematisch literatuuroverzicht},
  journal = {Tijdschrift voor Geneeskunde en Gezondheidszorg},
  year = {2026},
  doi = {10.47671/tvg.82.26.018}
}
Kostenlos starten →